FFA
UTHR icon

Farther Finance Advisors’s United Therapeutics UTHR Stock Holding History

Farther Finance Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$383K Sell
707
-605
-46% -$313K ﹤0.01% 1804
2026
Q2 		$712K Buy
1,312
+494
+60% +$278K 0.01% 1312
2026
Q1 		$466K Sell
818
-79
-9% -$39.3K ﹤0.01% 1446
2025
Q4 		$437K Buy
897
+720
+407% +$335K ﹤0.01% 1397
2025
Q3 		$74.2K Buy
177
+106
+149% +$35.6K ﹤0.01% 2216
2025
Q2 		$20.4K Sell
71
-385
-84% -$115K ﹤0.01% 2661
2025
Q1 		$140K Buy
456
+77
+20% +$26.4K ﹤0.01% 1382
2024
Q4 		$134K Buy
379
+23
+6% +$8.45K ﹤0.01% 1184
2024
Q3 		$128K Buy
356
+310
+674% +$105K ﹤0.01% 1198
2024
Q2 		$14.7K Buy
46
+12
+35% +$3.18K ﹤0.01% 1904
2024
Q1 		$7.76K Sell
34
-28
-45% -$6.32K ﹤0.01% 1861
2023
Q4 		$13.6K Buy
62
+21
+51% +$4.84K ﹤0.01% 1470
2023
Q3 		$9.26K Sell
41
-1
-2% -$230 ﹤0.01% 1312
2023
Q2 		$9.27K Buy
42
+7
+20% +$1.55K ﹤0.01% 1223
2023
Q1 		$7.84K Hold
35
– – ﹤0.01% 1201
2022
Q4 		$9.73K Buy
+35
New +$8.84K ﹤0.01% 949

Other funds holding UTHR

AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
VFP
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
BTC
Bank & Trust Company Litchfield, Illinois $159M AUM 30.15% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return
SRS
Strong Retirement Solutions Silverdale, Washington $178M AUM 20.42% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

Farther Finance Advisors's UTHR Position: Q3 2026 in Review

Farther Finance Advisors reduced its United Therapeutics (UTHR) stake by 46% in Q3 2026, selling an estimated $313K and leaving 707 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #1804.

Farther Finance Advisors first reported a position in UTHR in Q4 2022 and has held it in 16 quarters since. The position peaked at $712K in Q2 2026. 18 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Farther Finance Advisors held 707 shares of United Therapeutics worth $383K as of Q3 2026.
  • Farther Finance Advisors sold 605 United Therapeutics shares in Q3 2026, an estimated $313K.
  • United Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1804 holding.
  • Farther Finance Advisors first reported a position in United Therapeutics in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's United Therapeutics position peaked at $712K in Q2 2026.
  • 18 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.